銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Viyash Scientific
VIYASH ?NSE

Viyash Scientific

?254.951.10 (0.43%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
253.00
Today’s high
260.00
52 week low
166.00
52 week high
277.35
Open price
253.70
Previous close
253.85
Live volume
24,78,353
Lower circuit
204.00
Upper circuit
305.90

Fundamentals

Market Cap
?11,097Cr
ROE
7.07%
P/E Ratio(TTM)
49.42
EPS(TTM)
5.14
P/B Ratio
3.81
Dividend Yield
0.00%
Industry P/E
33.86
Book Value
66.63
Debt to Equity
0.17
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?936
+7.28%
Profit (Cr)
?66.38
+36.81%
02505007501k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+132%
3Y CAGR+3%
Profit growthValue
1Y (TTM)+539%
3Y CAGR-10%

About

SeQuent Scientific Limited stands as India's foremost animal health player, demonstrating an expanding global presence with state-of-the-art manufacturing capabilities across multiple continents. Its core vision is to establish itself as a premier integrated animal health company dedicated to delivering high-quality veterinary solutions around the world. The company's mission focuses on competitively delivering quality products while upholding strict standards of quality, governance, and compliance in all its operations. It offers an integrated portfolio that includes Active Pharmaceutical Ingredients (APIs) and Finished Drug Formulations (FDFs) to meet the industry's evolving needs. Through its animal health brand Alivira, the company is focused on advancing veterinary care by offering solutions that promote the well-being of animals. The company maintains a vast global reach with product registrations across numerous dosage forms, serving customers in over 90 countries.;
CEO/MD
Mr. Rajaram Narayanan
Founded in
1985
NSE symbol
VIYASH

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
61.31%
Retail And Others
27.76%
Mutual Funds
6.44%
Foreign Institutions
2.94%
Other Domestic Institutions
1.54%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,433.50
-95.50 (1.12%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,533.70
    -5.60 (0.12%)
    L
      H
      20,766.7328.744.94
      ?1,448.40
      +17.80 (1.24%)
      L
        H
        19,822.7430.615.08
        ?786.90
        +4.80 (0.61%)
        L
          H
          19,386.3932.583.81
          Livesquawk ?
          Viyash Scientific's Q4 net profit rose to ?521M from a ?262M loss YoY. Q4 revenue increased to ?9.2B from ?7.7B YoY.
          2026
          19
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com